We are live on ! Find out more
PC

Pavadi Capital Portfolio holdings

AUM $81.2M
1-Year Est. Return 5.26%
This Fund
S&P 500
This Quarter Est. Return
-6.6%
1 Year Est. Return
+5.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$113M
AUM Growth
-$18.3M
Cap. Flow
-$11.5M
Cap. Flow %
-10.13%
Top 10 Hldgs %
52.42%
Holding
27
New
5
Increased
–
Reduced
20
Closed
2

Top Buys

Rank Stock Value
1
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$5.49M
2
AMN icon
AMN Healthcare
AMN
+$5.39M
3
INMD icon
InMode
INMD
+$5.34M
4
CYH icon
Community Health Systems
CYH
+$3.16M
5
COR icon
Cencora
COR
+$934K

Top Sells

Rank Stock Value
1
MCK icon
McKesson
MCK
+$7.41M
2
BAX icon
Baxter International
BAX
+$6.25M
3
ZBH icon
Zimmer Biomet
ZBH
+$5.89M
4
PHG icon
Philips
PHG
+$1.46M
5
MOH icon
Molina Healthcare
MOH
+$1.17M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MOH icon
1
Molina Healthcare
MOH
$10.2B
$8.24M 7.26%
24,701
-3,803
-13% -$1.17M
CNC icon
2
Centene
CNC
$30.7B
$7.51M 6.62%
89,214
-13,723
-13% -$1.13M
THC icon
3
Tenet Healthcare
THC
$20.5B
$6.86M 6.04%
79,770
-7,382
-8% -$606K
CAH icon
4
Cardinal Health
CAH
$53.9B
$6.4M 5.64%
112,853
-10,457
-8% -$560K
AMN icon
5
AMN Healthcare
AMN
$1.3B
$5.41M 4.77%
+51,872
New +$5.39M
DGX icon
6
Quest Diagnostics
DGX
$25.7B
$5.31M 4.68%
38,812
-3,592
-8% -$501K
SYNH
7
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$5.25M 4.63%
+64,871
New +$5.49M
HOLX
8
DELISTED
Hologic
HOLX
$5M 4.41%
65,108
-6,030
-8% -$434K
UHS icon
9
Universal Health Services
UHS
$10.2B
$4.78M 4.21%
32,983
-6,380
-16% -$882K
LH icon
10
Labcorp
LH
$25.4B
$4.73M 4.17%
20,876
-1,933
-8% -$455K
MRVI icon
11
Maravai LifeSciences
MRVI
$969M
$4.7M 4.14%
133,279
-12,331
-8% -$413K
CVS icon
12
CVS Health
CVS
$133B
$4.44M 3.91%
43,831
-6,738
-13% -$708K
INMD icon
13
InMode
INMD
$870M
$4.4M 3.88%
+119,255
New +$5.34M
XRAY icon
14
Dentsply Sirona
XRAY
$2.68B
$4.28M 3.77%
86,966
-8,048
-8% -$425K
FLGT icon
15
Fulgent Genetics
FLGT
$470M
$4.26M 3.76%
68,333
-6,328
-8% -$417K
UNH icon
16
UnitedHealth
UNH
$376B
$4M 3.53%
7,854
-1,206
-13% -$582K
HUM icon
17
Humana
HUM
$43.7B
$4M 3.52%
9,186
-1,405
-13% -$588K
HCA icon
18
HCA Healthcare
HCA
$87.2B
$3.79M 3.34%
15,120
-2,321
-13% -$583K
ELV icon
19
Elevance Health
ELV
$81.5B
$3.78M 3.33%
7,694
-1,182
-13% -$540K
PHG icon
20
Philips
PHG
$25.7B
$3.69M 3.25%
146,311
-53,620
-27% -$1.46M
CI icon
21
Cigna
CI
$73.8B
$3.43M 3.02%
14,311
-2,198
-13% -$515K
QDEL icon
22
QuidelOrtho
QDEL
$1.14B
$3.25M 2.86%
28,893
-2,678
-8% -$285K
CYH icon
23
Community Health Systems
CYH
$393M
$3.08M 2.72%
+259,719
New +$3.16M
MCK icon
24
McKesson
MCK
$100B
$1.87M 1.65%
6,102
-27,234
-82% -$7.41M
COR icon
25
Cencora
COR
$60.6B
$1.02M 0.9%
+6,598
New +$934K
1
2

Similar funds

BAM
Broadmark Asset Management San Francisco, California $80.4M AUM 29.98% 1-Year Est. Return
TCM
Tegean Capital Management New York $82.1M AUM 12.91% 1-Year Est. Return
JAM
JLP Asset Management New York $84.2M AUM 10.86% 1-Year Est. Return
HH
HP Holding New York $84.5M AUM 4.73% 1-Year Est. Return
CPI
Canaan Partners IX Menlo Park, California $87.5M AUM
SLM
Snow Lake Management Menlo Park, California $90.7M AUM 72.65% 1-Year Est. Return
AFG
Alterity Financial Group Bangor, Maine $69.9M AUM 40.65% 1-Year Est. Return
TIMH
Tilt Investment Management Holdings New York $92.6M AUM 28.92% 1-Year Est. Return

Pavadi Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Pavadi Capital held 27 positions worth $113M, down 14% from $132M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Pavadi Capital withdrew a net $11.5M in Q1 2022, closing 2 positions and reducing 20 holdings. Its most notable exit was Baxter International, an estimated $6.25M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Pavadi Capital opened a new position in Syneos Health, Inc. Class A Common Stock worth $5.25M.

  • Pavadi Capital's largest Q1 2022 buy was Syneos Health, Inc. Class A Common Stock: 64,871 shares worth $5.25M.
  • Pavadi Capital's biggest Q1 2022 reduction was McKesson, cutting an estimated $7.41M.
  • Pavadi Capital fully exited Baxter International in Q1 2022, selling an estimated $6.25M.
  • Pavadi Capital's ten largest holdings make up 52% of its $113M portfolio in Q1 2022.
  • Pavadi Capital opened 5 new positions and closed 2 in Q1 2022.
  • Pavadi Capital's portfolio value fell 14% quarter-over-quarter to $113M.

Based on Pavadi Capital's 13F filing for Q1 2022, filed 16 May 2022.